<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Ghicavâi, V.I.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Coreţchi, I.G.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
</creators>
<titles>
<title xml:lang='en'>Method of prophylaxis of hypotension when using angiotensin 1 conversion enzyme inhibitors in the treatment of cardiovascular diseases</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2020</publicationYear>
<relatedIdentifier relatedIdentifierType='ISBN' relationType='IsPartOf'></relatedIdentifier>
<dates>
<date dateType='Issued'>2020</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Conference Paper</resourceType>
<descriptions>
<description xml:lang='en' descriptionType='Abstract'><p>The invention relates to experimental medicine, clinical pharmacology and intensive care and can be used for the prophylaxis of hypotension when using angiotensin 1 conversion enzyme inhibitors in the treatment of cardiovascular diseases. The essence of the invention is that 2&hellip;4 mg/kg of an angiotensin 1 conversion enzyme inhibitor is administered intravenously and then 10&hellip;20 mg/kg of S-ethylisothiuronium bromide solution is administered intravenously. The advantages of the method consist in the fact that the administration of S-ethylisothiuronium bromide prevents excessive reduction of BP, or increases BP, with stabilization of its values.</p></description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>